Project ECHO: Prevention and Management of Diabetes and Cardiometabolic Disorders in Community Health Centers
Image For Activity Cover
6 Courses
Expires on Dec 31, 2023
Credit Offered
6 AMA PRA Category 1 Credits
6 Participation Credits
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended
The Endocrine Society has launched an ECHO series focused on the management of diabetes and cardiometabolic disorders in federally qualified health centers (FQHCs).

This program explores diabetes and cardiometabolic care from the endocrine perspective and the factors unique to the health center community, such as the need for clinical care integration and mindfulness towards health disparities. This 6-ECHO series will focus on approaches to cardiometabolic care and management in the primary care, and typically rural, setting and how to bring best practices to this unique arena. The ECHOs will incorporate endocrinologists and FQHC staff, such as certified diabetes educators, nurses, and behavioral health specialists, as they explore the many ways to manage diabetes and its comorbidities (such as depression, cardiovascular disease, hypertension, etc.) as well as considerations when working with the special populations FQHCs serve. This series will bridge the gap between specialty endocrine care and the primary care setting by focusing on FQHCs and their unique placement within these special populations.
The target audience for this ECHO series will be FQHC physicians, nurses, pharmacists, and care teams responsible for managing patients with diabetes and cardiometabolic diseases within the primary care and community health center context. It may also be of interest to other primary care providers and endocrinologists interested in providing diabetes care to special populations.
Upon completing this series, learners will be able to:
  • Develop a practice of collaborative problem solving related to difficult diabetes cases, especially within vulnerable patient populations.
  • Discuss best practices related to interdisciplinary care for FQHC patients with complex endocrine disease, including medical and behavioral health interventions.
  • Analyze the impact of social determinants of health on endocrine disease and learn skills to engage complex patients in addressing health disparities.
  • Evaluate tools for working with complex endocrine disease patients remotely.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

For questions about content or obtaining CME credit, please contact the Endocrine Society at


Nicolas Cuttriss, MD - Program Co-Chair
Exploring the Relationship Between Diabetes and Cardiometabolic Disease June 15, 2022
Christopher E. West, PhD, A-GNP-C
Open Door Community Health Center 
Managing Insulin-Requiring Diabetes in Vulnerable Populations July 20, 2022
Jay Shubrook, DO
Touro University California
Treatment Strategies for Vulnerable Populations with Diabetes Not Requiring Insulin August 17, 2022
Kate Kirley, MD
American Medical Association
Managing Pre-Diabetes  September 14, 2022
Elizabeth Beverly, PhD
Ohio University 
Diabetes, Depression, and Behavioral Health October 12, 2022
Rayhan Lal, MD - Program Co-Chair
Stanford University of Medicine 
Role of Technology in Managing Diabetes in Rural Communities  November 16, 2022

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following faculty reported relevant financial relationships: Elizabeth Beverly, PhD - Journal of Osteopathic Medicine, Section Editor.  Nicolas Cuttriss, MD - ENDO Diabetes & Wellness, Employer; ECHO Diabetes Action Network, Employer; The Leona M. and Harry B. Helmsley Charitable Trust, Consultant; Cecelia Health; Consultant; American Youth Understanding Diabetes Abroad, Board. Kate Kirley, MD - American Medical Association, Employer. Rayhan Lal, MD - Abbott Diabetes Care, Consultant; Biolinq, Consultant; Capillary Biomedical, DSMB; Deep Valley Labs, Consultant; Gluroo, Consultant; Provention Bio, Advisory Board; Tidepool, Consultant. Jay Shubrook, DO - Abbott Diabetes Care, Consultant and Advisor; NovoNordisk, Consultant; Astra Zeneca, Advisor; Bayer, Advisor; Eli Lilly, Advisor; Nevro and Nevro, Advisor. 

The following faculty reported no relevant financial relationships: Christopher E. West, PhD, A-GNP-C 

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

This educational activity is supported by an independent medical educational grant from Abbott Diabetes Care Inc.
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Android App Download IOS App Download Powered By